Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison

• Main Authors: David Cherney (Author), Kerstin Folkerts (Author), Paul Mernagh (Author), Mateusz Nikodem (Author), Joerg Pawlitschko (Author), Peter Rossing (Author), Neil Hawkins (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study aimed to close an evidence gap concerning the relative efficacy of finerenone versus SGLT2is in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Canagliflozin was selected as a proxy for the SGLT2i class. Patient-level data of two randomized controlled trials (RCTs) o...